Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Compositions and methods including recombinant B lymphocyte cell line including at least one endogenous gene expressing at least one endogenous membrane immunoglobulin reactive to a first antigen and including at least one exogenously incorporated nucleic acid expressing at least one exogenous secreted immunoglobulin reactive to a second antigen

US Patent 9901598 · Granted Feb 27, 2018

Assignee

Inventors

View full patent text on Google Patents →